Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.
about
Malignant Biliary Obstruction: Evidence for Best PracticeGemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study.Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysisHyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
P2860
Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@ast
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@en
type
label
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@ast
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@en
prefLabel
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@ast
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@en
P2093
P2860
P1476
Phase II study of gemcitabine ...... tastatic biliary tract cancer.
@en
P2093
Choong Kee Park
Dae Ro Choi
Dae Young Zang
Ho Young Kim
Hong Il Ha
Hunho Song
Hyeong Su Kim
Jang Yong Jeon
P2860
P2888
P304
P356
10.1007/S00280-015-2687-X
P577
2015-01-29T00:00:00Z
P6179
1052581750